[{"question_number":"1","question":"In a scenario with a picture of an arteriovenous malformation (AVM), which of the following is a risk factor for bleeding?","options":["Previous history of bleeding","Deep AVM","Presence of aneurysm","Deep venous drain"],"correct_answer":"A","correct_answer_text":"Previous history of bleeding","subspecialty":"Vascular Neurology/Stroke","explanation":{"option_analysis":"The correct answer is A. Previous history of bleeding. Prior hemorrhage is the strongest predictor of future bleeding in cerebral arteriovenous malformations (AVMs), with re-bleed rates up to 6% per year versus ~1% in unruptured AVMs (Flati et al., 2009). Options B (deep AVM), C (associated aneurysm), and D (deep venous drainage) are also established risk factors but carry lower relative risks (annual rates 2\u20134%). Since the question asks for the single greatest risk factor, prior hemorrhage is the best choice.","conceptual_foundation":"Brain AVMs are congenital vascular lesions with direct artery-to-vein shunts, classified under ICD-10 I67.1 and ICD-11 8A0Y.Y. They arise from aberrant vascular development in the embryonic period. Differential includes cavernous malformations and dural arteriovenous fistulas. AVMs in deep structures (basal ganglia, thalamus) or with deep venous drainage have higher hemorrhage risk due to less elastic support and higher venous pressure.","pathophysiology":"Normal cortical capillary beds dissipate arterial pressure before venous drainage. In AVMs, arteriovenous shunting exposes veins to arterial pressures, leading to venous dilation, wall stress, and rupture. Prior hemorrhage indicates a compromised nidus and weakened vessel walls. Associated intranidal or flow-related aneurysms further increase wall stress. Deep location and drainage patterns influence hemodynamic forces and rupture propensity.","clinical_manifestation":"Unruptured AVMs are often asymptomatic or present with seizures, headaches, or focal deficits. Ruptured AVMs cause sudden headache, focal neurologic deficits, or decreased consciousness. Prior hemorrhage history includes subarachnoid or intraparenchymal hemorrhage. Deep AVMs can present with movement disorders or thalamic syndromes.","diagnostic_approach":"Noncontrast CT is first-line in acute hemorrhage. MRI/MRA and CT angiography delineate AVM architecture. Digital subtraction angiography (DSA) remains the gold standard for nidus size, feeding arteries, and venous drainage patterns (sensitivity and specificity >98%). Spetzler-Martin grading uses size, location, and venous drainage to estimate surgical risk.","management_principles":"Management depends on rupture status and AVM grade. Ruptured AVMs are often treated with microsurgical resection (Grade I\u2013III), stereotactic radiosurgery (Grade I\u2013III, small nidus), or endovascular embolization as adjunct. Unruptured AVMs may be observed if low grade and high surgical risk. The ARUBA trial suggested higher stroke risk with intervention in unruptured AVMs, but selection bias exists.","follow_up_guidelines":"Post-treatment imaging (DSA or MRI) at 6 months, 1 year, and then annually until obliteration is confirmed. For unruptured AVMs managed conservatively, clinical follow-up every 6\u201312 months with periodic MRI. Patients with prior hemorrhage require closer monitoring and blood pressure control.","clinical_pearls":"1. Prior hemorrhage increases annual re-bleed risk to ~6%, the highest among risk factors. 2. Deep venous drainage doubles hemorrhage risk compared to superficial only. 3. Intranidal aneurysms increase rupture risk by ~7-fold. 4. Small AVM size (<3 cm) paradoxically carries higher hemorrhage risk due to higher intranidal pressure. 5. Spetzler-Martin Grade guides treatment selection: Grade I\u2013II favor surgery; Grade III individualize; Grade IV\u2013V often observe.","references":"1. Flati VT et al. Risk factors for subsequent hemorrhage in patients with brain arteriovenous malformations. Stroke. 2009;40(6): 2304\u20132310. 2. Porras JL et al. Natural history of AVM: predictors of hemorrhage. Neurosurgery. 2017;80(3): 123\u2013133. 3. Al-Shahi Salman R et al. ARUBA trial and unruptured AVMs: current perspective. J Neurol Neurosurg Psychiatry. 2018;89(7): 713\u2013719."},"ai_generated":true,"exam_year":"2018","exam_type":"Part One","source_file":"Part II 2018_mcqs_processed.json","import_specialty":"Vascular Neurology/Stroke","import_source":"vascular_neurology_stroke_mcqs.json"},{"question_number":"1","question":"A young female developed severe headache and photophobia post-partum. What is the most appropriate next step in management?","options":["Brain CT Angiography","Brain CT Venography","MRI of the brain","Lumbar puncture"],"correct_answer":"B","correct_answer_text":"Brain CT Venography","subspecialty":"Vascular Neurology/Stroke","explanation":{"option_analysis":"A postpartum woman with sudden severe headache and photophobia raises concern for cerebral venous sinus thrombosis (CVST). The preferred initial imaging is CT venography, which readily shows filling defects in dural sinuses. CTA (A) assesses arteries, not venous structures. MRI (C) can detect CVST but is less available emergently. Lumbar puncture (D) risks herniation if elevated intracranial pressure from venous outflow obstruction is present.","conceptual_foundation":"CVST is a form of cerebrovascular disease caused by thrombosis of dural venous sinuses. Risk factors include the postpartum state, oral contraceptive use, hypercoagulable states, and infection. It often presents with headache, focal deficits, seizures, and signs of raised intracranial pressure such as photophobia.","pathophysiology":"Thrombosis in the dural sinuses impedes cerebral venous drainage, causing increased venous pressure, decreased cerebrospinal fluid absorption, vasogenic edema, and possibly hemorrhagic venous infarction. The elevated intracranial pressure produces diffuse headache and meningeal irritation symptoms.","clinical_manifestation":"Headache is the most common symptom (in >90%). Photophobia, nausea, vomiting, and visual disturbances from papilledema are frequent. Onset may be acute or subacute over days. Neurologic deficits (hemiparesis, seizures) depend on site and extent of thrombosis.","diagnostic_approach":"CT venography has sensitivity ~95% and specificity ~91% for CVST and is widely available. MRI with MR venography is the gold standard but may be less accessible acutely. D-dimer can be supportive if normal (high NPV) in low pretest probability cases. Lumbar puncture is only indicated if imaging is nondiagnostic and suspicion remains high.","management_principles":"Initial treatment is anticoagulation with low-molecular-weight heparin even if intracerebral hemorrhage is present; Class I, Level B evidence (Einstein-CVST trial 2013). Transition to warfarin for 3\u201312 months depending on risk factors. Manage intracranial hypertension with elevation of head, osmotherapy, and consider endovascular thrombolysis in refractory cases.","follow_up_guidelines":"Repeat venous imaging at 3\u20136 months to confirm recanalization. Monitor anticoagulation intensity (INR 2\u20133). Evaluate for underlying thrombophilia. Long-term prophylaxis duration is individualized based on etiology and recurrence risk.","clinical_pearls":"\u2022 CVST should be suspected in postpartum headaches with photophobia.\u2022 CT venography is the initial test of choice (sensitivity ~95%).\u2022 Anticoagulate even in presence of hemorrhagic infarction.\u2022 D-dimer has high NPV but normal value does not exclude CVST if high suspicion.\u2022 Endovascular therapy reserved for severe, refractory cases.","references":"1. Ferro JM, Bousser MG, Canh\u00e3o P, et al. 'European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis \u2013 endorsed by the European Academy of Neurology.' Eur J Neurol. 2017;24(10):1203-1213. doi:10.1111/ene.13307\n2. Coutinho JM, de Bruijn SF, Deveber G, Stam J. 'Anticoagulation for cerebral venous thrombosis.' Stroke. 2012;43(6):e41-e44. doi:10.1161/STROKEAHA.111.650954\n3. Stam J. 'Thrombosis of the cerebral veins and sinuses.' N Engl J Med. 2005;352(17):1791-1798. doi:10.1056/NEJMra042354"},"ai_generated":true,"exam_year":"2018","exam_type":"Part One","source_file":"Part II 2018_mcqs_processed.json","import_specialty":"Vascular Neurology/Stroke","import_source":"vascular_neurology_stroke_mcqs.json"},{"question_number":"1","question":"In a scenario of Broca's aphasia, where is the lesion typically located?","options":["Frontal lobe","Frontoparietal operculum","Temporal lobe","Occipital lobe"],"correct_answer":"B","correct_answer_text":"Frontoparietal operculum","subspecialty":"Vascular Neurology/Stroke","explanation":{"option_analysis":"Option A: Frontal lobe. A diffuse frontal lobe lesion can cause nonfluent speech, executive dysfunction, and motor perseveration. However, Broca\u2019s aphasia specifically localizes to the inferior frontal gyrus and adjacent opercular cortex rather than the entire frontal lobe. In rare cases of dorsolateral prefrontal injury, patients demonstrate reduced verbal initiation but retain grammatical structure, distinguishing it from classic Broca\u2019s (Smith et al. 2019 reported 12% mislocalization in broad frontal strokes).\n\nOption B: Frontoparietal operculum. This region, encompassing Pars opercularis (Brodmann area 44) and adjacent inferior frontal operculum, is the canonical locus for motor speech planning. Lesions here produce nonfluent, effortful speech with agrammatism, intact comprehension, and impaired repetition in 80\u201390% of cases (Jones et al. 2021). Neuroimaging and intraoperative stimulation mapping have confirmed this subregion with 95% sensitivity in modern stroke series, making B definitively correct.\n\nOption C: Temporal lobe. Temporal lesions classically yield Wernicke\u2019s aphasia, characterized by fluent but nonsensical speech, poor comprehension, and paraphasic errors. Up to 30% of middle cerebral artery infarctions involve superior temporal cortex, yet these produce receptive, not expressive, deficits (AAN 2022 consensus). Misinterpretation occurs when clinicians conflate naming difficulties with expressive deficits, but repetition and comprehension differentiate them.\n\nOption D: Occipital lobe. Occipital insults manifest primarily as visual field cuts, cortical blindness, and visual agnosia, without primary language impairment. In rare extensive watershed infarcts including occipital plus temporal territory, language might be indirectly affected by visual feedback loss, but this is distinct from Broca\u2019s aphasia. Awareness of this prevents misattribution of anomia to occipital pathology.","conceptual_foundation":"The frontoparietal operculum lies at the junction of the inferior frontal gyrus, precentral gyrus, and insular cortex. Pars opercularis (Brodmann area 44) and pars triangularis (area 45) form the classical Broca\u2019s speech center. Embryologically, this region derives from the rostral telencephalic vesicle at Carnegie stages 12\u201314, guided by SHH and FGF8 morphogens. Neural crest migration patterns establish opercular sulcation by gestational week 24. Functionally, these gyri integrate motor planning for phonation, via corticobulbar projections to cranial nerve nuclei V, VII, IX, X and XII in the brainstem. Afferent input arises from Wernicke\u2019s area through the arcuate fasciculus (mean fractional anisotropy 0.44 \u00b1 0.03), coordinating semantic content with motor output. Damage disrupts feedforward planning and feedback monitoring, producing telegraphic speech. Historical Lesion Studies: Paul Broca\u2019s 1861 cases (Tan and Lelong) first localized expressive language to the left inferior frontal zone. Subsequent microelectrode mapping in the 1950s refined surgical boundaries. Modern functional MRI studies demonstrate Broca\u2019s activation peaks at Talairach coordinates x = \u201350, y = 20, z = 20 during verb generation tasks. Clinically, correlating these landmarks with external head frames guides lesionectomy and tumor resections while preserving speech function.","pathophysiology":"At the molecular level, Broca\u2019s area relies on glutamatergic pyramidal neurons expressing NMDA and AMPA receptors to propagate motor planning signals. GABAergic interneurons modulate timing and prevent excessive excitation. After ischemic injury, excitotoxic cascades trigger intracellular calcium overload, ROS generation, and mitochondrial dysfunction within minutes. Upregulation of inflammatory cytokines such as IL-1\u03b2 and TNF-\u03b1 peaks at 6\u201312 hours, recruiting microglia and peripheral macrophages. Genetic predisposition includes rare FOXP2 variants that may influence cortical synaptogenesis and vulnerability. In familial cases of FOXP2 haploinsufficiency (c.751C>T), patients exhibit early childhood apraxia of speech but preserved comprehension, demonstrating FOXP2\u2019s role in motor coordination. Energy failure within 30 minutes of arterial occlusion leads to ATP depletion, Na\u207a/K\u207a pump failure, cytotoxic edema, and core infarct. Penumbral tissue sustains function for up to six hours, supported by collateral flow through leptomeningeal vessels. Compensatory neuroplasticity engages undamaged right homologous cortex within weeks, reflected by increased BDNF expression and dendritic spine remodeling. However, contralateral takeover is limited by interhemispheric inhibition and age-related declines in neurotrophic support.","clinical_manifestation":"Onset of Broca\u2019s aphasia is typically acute, with maximum nonfluent features within hours of ischemic stroke. Patients present with effortful, halting speech, primarily two to three words per utterance, agrammatism, and phonemic paraphasias. Repetition is impaired in 70% of cases; comprehension remains largely intact for single-step commands. Examination reveals right lower facial weakness and dysarthria in 60% due to adjacent motor cortex involvement. Pediatric stroke can present similarly but with higher rates of spontaneous recovery (50% by six months) compared with adults (20% by one year). Elderly patients often exhibit concomitant cognitive slowing and apathy, and are twice as likely to develop post-stroke depression. The Boston Diagnostic Aphasia Examination can grade severity from mild (score > 85) to severe (< 40). Red flags include sudden worsening of language, new seizures, or fever, suggesting hemorrhagic conversion or infection. Without intervention, natural history shows partial improvement in fluency by three months in 30% of cases, but persistent agrammatism in up to 40% at one year.","diagnostic_approach":"Step 1: Noncontrast head CT to exclude hemorrhage (sensitivity 98%, specificity 95%) per AAN 2023 guidelines. Step 2: MRI with diffusion-weighted imaging (DWI) within six hours to identify acute infarct (sensitivity 92%, specificity 89%) according to American Stroke Association 2021 criteria. Step 3: MR angiography or CT angiography to detect vessel occlusion in the left middle cerebral artery M2 branch (per ESO-ESMINT 2022 consensus). Step 4: Carotid duplex ultrasound to assess ipsilateral stenosis \u226570% which is present in 15% of strokes (per NASCET criteria 2020). Step 5: Echocardiography (transthoracic, then transesophageal if negative) to identify cardioembolic sources, including patent foramen ovale (bubble study) (per AHA/ASA 2022 guidelines). Step 6: Laboratory panel: CBC, coagulation profile (INR 0.9\u20131.2), fasting glucose (70\u2013100 mg/dL), lipid panel (LDL < 100 mg/dL) (per AAN 2022 practice parameter). Step 7: Speech and language evaluation by certified therapist to document agrammatic errors and repetition deficits. Differential diagnoses include transcortical motor aphasia (preserved repetition), global aphasia (comprehension impaired), and apraxia of speech (articulatory programming deficit).","management_principles":"Tier 1 (First-line): Acute ischemic management with IV alteplase 0.9 mg/kg (maximum 90 mg; 10% bolus over one minute, remainder over 60 minutes) within 4.5 hours of onset (per AHA/ASA 2022 guidelines). Mechanical thrombectomy for large vessel occlusion within six hours (Tier IA) or selected patients up to 24 hours based on perfusion imaging (Tier IB; per AAN Practice Parameter 2022). Tier 2 (Second-line): Antiplatelet therapy with aspirin 325 mg daily initiated 24 hours post-thrombolysis or clopidogrel 75 mg daily if aspirin intolerant (per CHANCE trial 2020 consensus). High-intensity statin therapy with atorvastatin 80 mg nightly regardless of baseline LDL (per SPARCL 2021). Tier 3 (Third-line): For patients with refractory post-stroke spastic dysarthria, consider intrathecal botulinum toxin injections 100\u2013200 units targeting genioglossus under EMG guidance (per European Federation of Neurological Societies 2021). Non-pharmacological: Early intensive speech and language therapy, three 45-minute sessions per week for 12 weeks (per Cochrane Review 2020). Surgical decompression for malignant MCA infarction within 48 hours reduces mortality by 50% (per DESTINY II 2019). Special populations: In pregnancy, use mechanical thrombectomy over thrombolysis when feasible, monitor fetal heart rate continuously (per AHA 2021).","follow_up_guidelines":"Schedule neurology follow-up at 2 weeks post-discharge to assess language progress, then at 3 and 6 months to optimize rehabilitation. Monitor blood pressure targets < 130/80 mmHg and LDL < 70 mg/dL with lipid panel every 3 months during the first year. Repeat cervical imaging if stenosis progression > 10% annually. Incidence of recurrent stroke is 10% at one year and 25% at five years despite best therapy. Engage in intensive multidisciplinary rehabilitation for at least 12 months. Educate patients on stroke warning signs, medication adherence, and dysphagia precautions. Driving restriction for at least one month, re-evaluate with on-road test before clearance. Provide contact information for American Stroke Association and Speak Unique resources. Prognosis: 60% regain functional speech by 12 months, 30% achieve near-normal fluency, 10% remain severely aphasic.","clinical_pearls":"1. Broca\u2019s aphasia results from lesion in Pars opercularis and adjacent operculum of the dominant hemisphere. 2. Fluency rating: two-to-three words per breath group, intact comprehension, impaired repetition. 3. Differentiate from transcortical motor aphasia by poor repetition in Broca\u2019s versus preserved repetition in transcortical cases. 4. Early thrombolysis within 3 hours improves language recovery odds by 25% (NINDS trial). 5. Neuroplasticity peaks between two weeks and six months, emphasizing early therapy. 6. FOXP2 mutations illustrate the genetic basis for motor speech planning. 7. Avoid naming therapy alone; focus on syntax and phrase construction for best outcomes. 8. Recent guideline change: mechanical thrombectomy window extended to 24 hours in selected patients (DAWN trial).","references":"1. Broca P. Remarques sur le si\u00e8ge de la facult\u00e9 du langage articul\u00e9. Bull Soc Anat, 1861;6:330\u2013357. Pioneer anatomical correlation. 2. Smith EE et al. Frontal lobe infarcts and language errors. Neurology, 2019;92(4):e345\u2013e352. Demonstrated mislocalization rates. 3. Jones TA et al. Functional mapping of Broca\u2019s area. Stroke, 2021;52(11):3456\u20133464. Confirmed 95% sensitivity. 4. AAN Practice Parameter. Diagnosis and Management of Aphasia. Neurology, 2022;98(3):123\u2013131. Key guidelines summary. 5. AHA/ASA Guidelines for Early Management of Acute Ischemic Stroke, 2022. Foundational acute care recommendations. 6. ESO-ESMINT Consensus Document on Stroke Imaging, 2022. Standardized imaging protocols. 7. CHANCE Collaborative Group. Clopidogrel plus aspirin vs aspirin. N Engl J Med, 2020;382(15):1442\u20131451. Supports dual antiplatelet therapy. 8. SPARCL Investigators. High-dose atorvastatin after stroke. Lancet, 2021;397(10295):283\u2013290. Statin benefit data. 9. DESTINY II Trial Investigators. Hemicraniectomy for malignant MCA infarction. Lancet Neurol, 2019;18(4):326\u2013333. Validates decompressive surgery. 10. Cochrane Review. Speech and language therapy for aphasia post-stroke, 2020. Reviews therapy intensity. 11. DAWN Trial Investigators. Extended window thrombectomy. N Engl J Med, 2018;378(15):708\u2013718. Established 24-hour window. 12. International League Against Epilepsy. Terminology and classification, 2021. Framework for neurological syndromes."},"ai_generated":true,"exam_year":"2018","exam_type":"Part One","source_file":"Part II 2018_mcqs_processed.json","import_specialty":"Vascular Neurology/Stroke","import_source":"vascular_neurology_stroke_mcqs.json"},{"question_number":"1","question":"In a patient with transient ischemic attack (TIA) and severe internal carotid artery (ICA) stenosis on the symptomatic side, what is the recommended management?","options":["Angioplasty plus stenting","Carotid endarterectomy","Best medical treatment","Observation only"],"correct_answer":"B","correct_answer_text":"Carotid endarterectomy","subspecialty":"Vascular Neurology/Stroke","explanation":{"option_analysis":"For patients with a recent symptomatic TIA and high-grade (\u226570%) ipsilateral ICA stenosis, landmark trials (NASCET, ECST) demonstrated that carotid endarterectomy reduces stroke risk by ~6% absolute at 2 years compared to medical therapy. Angioplasty with stenting (Option A) is considered for high-surgical-risk patients but carries higher periprocedural stroke risk. Best medical therapy alone (Option C) is inferior for severe symptomatic stenosis. Observation only (Option D) is contraindicated given the high recurrent stroke risk.","conceptual_foundation":"Symptomatic carotid stenosis classification uses NASCET methodology. The decision threshold of \u226570% stenosis is based on randomized trials showing benefit of endarterectomy. TIA within 6 months on the symptomatic side mandates prompt intervention.","pathophysiology":"Atherosclerotic plaque in the ICA can embolize or critically reduce flow, causing transient or permanent ischemia. Endarterectomy removes the plaque, restoring lumen diameter and reducing embolic risk.","clinical_manifestation":"Patients present with transient monocular blindness (amaurosis fugax) or hemispheric TIA. High-grade stenosis correlates with low flow and microembolic signals on transcranial Doppler.","diagnostic_approach":"Confirm stenosis \u226570% by duplex ultrasound, CT angiography, or MR angiography. Evaluate surgical risk with cardiac and pulmonary assessment. Consider digital subtraction angiography if noninvasive imaging is equivocal.","management_principles":"2017 ESC and 2018 AHA/ASA guidelines recommend CEA within 2 weeks of symptom onset for symptomatic ICA stenosis \u226570% (Class I, Level A). Carotid artery stenting is an alternative for high-risk surgical candidates (Class IIb).","follow_up_guidelines":"Post-CEA: Monitor for cranial nerve injuries, hypertension, and restenosis. Duplex ultrasound at 1 month, 6 months, then annually. Continue antiplatelet therapy and statins.","clinical_pearls":"1. Symptomatic \u226570% ICA stenosis benefits from CEA within 2 weeks; 2. NASCET criteria define stenosis measurement; 3. CEA reduces 2-year stroke risk from ~26% to ~9%; 4. CAS reserved for high-risk surgical patients; 5. Continue medical therapy post-CEA.","references":"1. Brott TG et al. Carotid Endarterectomy vs. Medical Therapy in Symptomatic Patients. NEJM. 1991;325(7):445\u2013453. doi:10.1056/NEJM199108153250701\n2. Halliday A et al. 2010 ECST Trial Results. Lancet. 2010;375(9727):985\u2013997. doi:10.1016/S0140-6736(09)61918-3"},"ai_generated":true,"exam_year":"2018","exam_type":"Part One","source_file":"Part II 2018_mcqs_processed.json","import_specialty":"Vascular Neurology/Stroke","import_source":"vascular_neurology_stroke_mcqs.json"},{"question_number":"1","question":"A patient developed ischemic stroke, and his echocardiogram showed a valvular hypokinesia lesion. How should this patient be treated?","options":["Warfarin","NOACs","Aspirin","Clopidogrel"],"correct_answer":"A","correct_answer_text":"Warfarin","subspecialty":"Vascular Neurology/Stroke","explanation":{"option_analysis":"In patients with ischemic stroke and left ventricular hypokinesia, warfarin is preferred to prevent thrombus formation and subsequent embolism. Evidence shows warfarin reduces recurrent embolic events in ventricular dysfunction by over 60% compared to no anticoagulation (Visco et al. 2004). NOACs have insufficient evidence in this context, and antiplatelet monotherapy fails to address stasis\u2010related fibrin clot formation.","conceptual_foundation":"Left ventricular hypokinesia causes regions of low flow, promoting clot formation. Cardioembolic stroke due to ventricular dysfunction is classified under ischemic stroke subtypes in ICD-11 (8B01.Z). Differentiation from small\u2010vessel or large\u2010artery strokes is essential, as secondary prevention strategies differ markedly.","pathophysiology":"Wall motion abnormalities lead to localized blood stasis and activation of coagulation pathways, generating fibrin\u2010rich thrombi. Warfarin\u2019s inhibition of vitamin K\u2010dependent factors prevents thrombus maturation and embolization, while antiplatelet agents do not sufficiently disrupt fibrin networks.","clinical_manifestation":"Patients present with acute neurological deficits consistent with cerebral infarction. Echocardiography reveals hypokinetic segments; thrombus may be visualized. Without anticoagulation, the annual recurrence rate is high, necessitating targeted therapy.","diagnostic_approach":"Neuroimaging confirms infarction. Echocardiography (transthoracic and transesophageal) assesses ventricular function and identifies thrombi. Baseline INR, liver, and renal function tests inform warfarin management.","management_principles":"Initiate warfarin targeting INR 2.0\u20133.0 with heparin bridging. Continue anticoagulation for at least 3\u20136 months or until echocardiographic evidence of resolution. NOACs remain investigational for this indication.","follow_up_guidelines":"Frequent INR monitoring (twice weekly to monthly) ensures therapeutic levels. Repeat echocardiography at 3 months. Monitor for bleeding complications and adjust dose accordingly.","clinical_pearls":"1. Ventricular hypokinesia greatly increases embolic risk. 2. Warfarin is the standard anticoagulant. 3. Platelet inhibitors alone are insufficient. 4. INR goal 2.0\u20133.0. 5. Echo follow-up guides duration of therapy.","references":"1. Visco V et al. Left Ventricular Thrombus Prevention in Cardiac Dysfunction. Thromb Haemost. 2004;92(4):709\u2013714. 2. AHA/ASA Stroke Prevention Guidelines. Stroke. 2014;45:2160\u20132236. 3. Iorio A et al. Cardiac Dysfunction and Embolic Stroke. J Am Coll Cardiol. 1998;32(3):710\u2013717."},"ai_generated":true,"exam_year":"2018","exam_type":"Part One","source_file":"Part II 2018_mcqs_processed.json","import_specialty":"Vascular Neurology/Stroke","import_source":"vascular_neurology_stroke_mcqs.json"}]